Label-free virtual HER2 immunohistochemical staining of breast tissue
  using deep learning
  The immunohistochemical (IHC) staining of the human epidermal growth factor
receptor 2 (HER2) biomarker is widely practiced in breast tissue analysis,
preclinical studies and diagnostic decisions, guiding cancer treatment and
investigation of pathogenesis. HER2 staining demands laborious tissue treatment
and chemical processing performed by a histotechnologist, which typically takes
one day to prepare in a laboratory, increasing analysis time and associated
costs. Here, we describe a deep learning-based virtual HER2 IHC staining method
using a conditional generative adversarial network that is trained to rapidly
transform autofluorescence microscopic images of unlabeled/label-free breast
tissue sections into bright-field equivalent microscopic images, matching the
standard HER2 IHC staining that is chemically performed on the same tissue
sections. The efficacy of this virtual HER2 staining framework was demonstrated
by quantitative analysis, in which three board-certified breast pathologists
blindly graded the HER2 scores of virtually stained and immunohistochemically
stained HER2 whole slide images (WSIs) to reveal that the HER2 scores
determined by inspecting virtual IHC images are as accurate as their
immunohistochemically stained counterparts. A second quantitative blinded study
performed by the same diagnosticians further revealed that the virtually
stained HER2 images exhibit a comparable staining quality in the level of
nuclear detail, membrane clearness, and absence of staining artifacts with
respect to their immunohistochemically stained counterparts. This virtual HER2
staining framework bypasses the costly, laborious, and time-consuming IHC
staining procedures in laboratory, and can be extended to other types of
biomarkers to accelerate the IHC tissue staining used in life sciences and
biomedical workflow.
